ARL17 anticorps (Middle Region)
Aperçu rapide pour ARL17 anticorps (Middle Region) (ABIN632378)
Antigène
Voir toutes ARL17 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Specificité
- ARL17 antibody was raised against the middle region of ARL17
-
Purification
- Affinity purified
-
Immunogène
- ARL17 antibody was raised using the middle region of ARL17 corresponding to a region with amino acids KCSHVEFGMWKGGRSHPFLPHSSRCAGSGGQLDSILPHQSPAWGPWGCKD
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
ARL17 Blocking Peptide, (ABIN939662), is also available for use as a blocking control in assays to test for specificity of this ARL17 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of ARL17 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- ARL17 (ADP-Ribosylation Factor-Like 17B (ARL17))
-
Autre désignation
- ARL17
-
Sujet
- ARL17 is a GTP-binding protein that functions as an allosteric activator of the cholera toxin catalytic subunit, an ADP-ribosyltransferase. ARL17 is involved in protein trafficking, may modulate vesicle budding and uncoating within the Golgi apparatus.
-
Poids moléculaire
- 19 kDa (MW of target protein)
Antigène
-